药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Levosimendan
Esketamine
The risk or severity of hypertension can be increased when Esketamine is combined with Metamfetamine.
Levosimendan
Potassium perchlorate
The risk or severity of adverse effects can be increased when Metamfetamine is combined with Potassium perchlorate.
Levosimendan
Thyrotropin
The risk or severity of adverse effects can be increased when Metamfetamine is combined with Thyrotropin.
Levosimendan
Benzylthiouracil
The risk or severity of adverse effects can be increased when Metamfetamine is combined with Benzylthiouracil.
Levosimendan
Elcatonin
The risk or severity of adverse effects can be increased when Metamfetamine is combined with Elcatonin.
Levosimendan
Methylthiouracil
The risk or severity of adverse effects can be increased when Metamfetamine is combined with Methylthiouracil.
Levosimendan
3,5-diiodothyropropionic acid
The risk or severity of adverse effects can be increased when Metamfetamine is combined with 3,5-diiodothyropropionic acid.
Levosimendan
Protirelin
The risk or severity of adverse effects can be increased when Metamfetamine is combined with Protirelin.
Levosimendan
Thyroid, porcine
The risk or severity of adverse effects can be increased when Metamfetamine is combined with Thyroid, porcine.
Levosimendan
Dibromotyrosine
The risk or severity of adverse effects can be increased when Metamfetamine is combined with Dibromotyrosine.
Levosimendan
Potassium Iodide
The risk or severity of adverse effects can be increased when Metamfetamine is combined with Potassium Iodide.
Levosimendan
Teriparatide
The risk or severity of adverse effects can be increased when Metamfetamine is combined with Teriparatide.
Levosimendan
Parathyroid hormone
The risk or severity of adverse effects can be increased when Metamfetamine is combined with Parathyroid hormone.
Levosimendan
Abaloparatide
The risk or severity of adverse effects can be increased when Metamfetamine is combined with Abaloparatide.
Levosimendan
Tiratricol
The risk or severity of adverse effects can be increased when Metamfetamine is combined with Tiratricol.
Levosimendan
3,5-Diiodotyrosine
The risk or severity of adverse effects can be increased when Metamfetamine is combined with 3,5-Diiodotyrosine.
Levosimendan
Liotrix
The risk or severity of adverse effects can be increased when Metamfetamine is combined with Liotrix.
Levosimendan
Lithium hydroxide
The therapeutic efficacy of Lithium hydroxide can be decreased when used in combination with Metamfetamine.
Levosimendan
Lithium carbonate
The therapeutic efficacy of Metamfetamine can be decreased when used in combination with Lithium carbonate.
Levosimendan
Lithium citrate
The therapeutic efficacy of Metamfetamine can be decreased when used in combination with Lithium citrate.